Mineralys Therapeutics plans first Philadelphia-area life sciences IPO of 2023


No Philadelphia-area life sciences companies went public through an IPO in 2022, after a combined 12 during the preceding two years.

Previous Bank economists see inflation weakening and growth stalling
Next Opinion: How Houston’s businesses are suffering amid the ‘crisis of wellbeing’